Life AI Net
Inicio
Archivo
Calculadoras
Directorio
Boletín
Hot
Iniciar sesión
Español
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Inicio
Archivo
Calculadoras
Directorio
Boletín
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Iniciar sesión
Inicio
Archivo
Calculadoras
Directorio
More
En vivo
FierceBiotech
Pulnovo Medical scores $100M in finance round led by Medtronic
Lonza News
Lonza Group AG stock (CH0013841017): Why biopharma contract manufacturing now matters more for U.S. - AD HOC NEWS
10x Genomics Blog
Is Atera’s New Spatial Biology Platform Altering The Investment Case For 10x Genomics (TXG)? - simplywall.st
Brady Corporation
Milwaukee’s Brady Corp Buying Honeywell Division - Seehafer News
FierceBiotech
Foundation Medicine expands Bristol Myers Squibb collaboration with new diagnostic target
FierceBiotech
In a Merck Litespark shocker, Welireg triplet misses the mark in first-line kidney cancer
FierceBiotech
Ray Therapeutics shines a light on $125M round targeting genetic eye therapy
FierceBiotech
Tortugas comes out of its shell with $106M to fund 4 phase 2-stage neuro drugs licensed from Asia
FierceBiotech
Pfizer's strategy head Andrew Baum to step down following brief tenure: reports
BioWorld
Pricing standoff leaves Australian patients in limbo
BioWorld
Mabwell turns to Hong Kong to fund ADC ambitions
BioWorld
Xuanzhu shares dip despite phase III ALK inhibitor data
FierceBiotech
Pulnovo Medical scores $100M in finance round led by Medtronic
Lonza News
Lonza Group AG stock (CH0013841017): Why biopharma contract manufacturing now matters more for U.S. - AD HOC NEWS
10x Genomics Blog
Is Atera’s New Spatial Biology Platform Altering The Investment Case For 10x Genomics (TXG)? - simplywall.st
Brady Corporation
Milwaukee’s Brady Corp Buying Honeywell Division - Seehafer News
FierceBiotech
Foundation Medicine expands Bristol Myers Squibb collaboration with new diagnostic target
FierceBiotech
In a Merck Litespark shocker, Welireg triplet misses the mark in first-line kidney cancer
FierceBiotech
Ray Therapeutics shines a light on $125M round targeting genetic eye therapy
FierceBiotech
Tortugas comes out of its shell with $106M to fund 4 phase 2-stage neuro drugs licensed from Asia
FierceBiotech
Pfizer's strategy head Andrew Baum to step down following brief tenure: reports
BioWorld
Pricing standoff leaves Australian patients in limbo
BioWorld
Mabwell turns to Hong Kong to fund ADC ambitions
BioWorld
Xuanzhu shares dip despite phase III ALK inhibitor data
Archivo
Buscar
Buscar
Reciente
Más antiguo
Borrar
@BioWorld
Total
1062
Fuente
BioWorld
Búsqueda
--
BioWorld
16 mar 2026
In the clinic for March 16, 2026
BioWorld
16 mar 2026
Regulatory actions for March 16, 2026
BioWorld
16 mar 2026
Other news to note for March 16, 2026
BioWorld
16 mar 2026
Pharma USA: Innovators, but architects, too; access is key
BioWorld
16 mar 2026
Precision psychiatry beyond, or before, biomarkers
BioWorld
16 mar 2026
Biggest gainers and losers for March 9-13, 2026
BioWorld
16 mar 2026
CD73-targeting immunoconjugates disclosed in Eisai patent
BioWorld
16 mar 2026
Kyron-Servier deal focused on programmable glycoprotein platform
BioWorld
13 mar 2026
In the clinic for Oct. 28, 2025
BioWorld
13 mar 2026
In the clinic for March 6, 2026
BioWorld
13 mar 2026
Money raised by biopharma
BioWorld
13 mar 2026
Biopharma money raised: Jan. 1-March 13, 2026
BioWorld
13 mar 2026
In the clinic for March 13, 2026
BioWorld
13 mar 2026
Other news to note for March 13, 2026
BioWorld
13 mar 2026
Regulatory actions for March 13, 2026
BioWorld
13 mar 2026
FDA ‘blacklist’ in DMD? Legislator slams PTC turndown
BioWorld
13 mar 2026
Med14 essential for GLP-1 agonist response, study finds
BioWorld
13 mar 2026
Council of Scientific and Industrial Research describes anticancer agents
Anterior
15 / 59
Siguiente